Carter BZ - Search Results

1

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

Milella M, Kornblau SM, Estrov Z, Carter BZ, Lapillonne H, Harris D, Konopleva M, Zhao S, Estey E, Andreeff M. Milella M, et al. Among authors: carter bz. J Clin Invest. 2001 Sep;108(6):851-9. doi: 10.1172/JCI12807. J Clin Invest. 2001. PMID: 11560954 Free PMC article.

2

Cytokine-regulated expression of survivin in myeloid leukemia.

Carter BZ, Milella M, Altieri DC, Andreeff M. Carter BZ, et al. Blood. 2001 May 1;97(9):2784-90. doi: 10.1182/blood.v97.9.2784. Blood. 2001. PMID: 11313272 Free article.

3

Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia.

Milella M, Estrov Z, Kornblau SM, Carter BZ, Konopleva M, Tari A, Schober WD, Harris D, Leysath CE, Lopez-Berestein G, Huang Z, Andreeff M. Milella M, et al. Among authors: carter bz. Blood. 2002 May 1;99(9):3461-4. doi: 10.1182/blood.v99.9.3461. Blood. 2002. PMID: 11964319 Free article.

4

Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.

Carter BZ, Kornblau SM, Tsao T, Wang RY, Schober WD, Milella M, Sung HG, Reed JC, Andreeff M. Carter BZ, et al. Blood. 2003 Dec 1;102(12):4179-86. doi: 10.1182/blood-2003-03-0960. Epub 2003 Aug 14. Blood. 2003. PMID: 12920030 Free article.

5

Targeting Survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells.

Carter BZ, Wang RY, Schober WD, Milella M, Chism D, Andreeff M. Carter BZ, et al. Cell Cycle. 2003 Sep-Oct;2(5):488-93. Cell Cycle. 2003. PMID: 12963850

6

Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia.

Carter BZ, Milella M, Tsao T, McQueen T, Schober WD, Hu W, Dean NM, Steelman L, McCubrey JA, Andreeff M. Carter BZ, et al. Leukemia. 2003 Nov;17(11):2081-9. doi: 10.1038/sj.leu.2403113. Leukemia. 2003. PMID: 12970762

7

Targeted therapy of AML new concepts.

Andreeff M, Milella M, Carter BZ, Tabe Y, Ricciardi MR, Sneed T, Ruvolo P, Contractor R, Tsao T, Schober W, Evans R, McQueen T, Zeng Z, Kornblau SM, McCubrey J, Estey E, Mills GB, Reed JC, Konopleva M. Andreeff M, et al. Among authors: carter bz. Ann Hematol. 2004;83 Suppl 1:S51-3. doi: 10.1007/s00277-004-0849-8. Ann Hematol. 2004. PMID: 15124670 No abstract available.

8

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

Carter BZ, Gronda M, Wang Z, Welsh K, Pinilla C, Andreeff M, Schober WD, Nefzi A, Pond GR, Mawji IA, Houghten RA, Ostresh J, Brandwein J, Minden MD, Schuh AC, Wells RA, Messner H, Chun K, Reed JC, Schimmer AD. Carter BZ, et al. Blood. 2005 May 15;105(10):4043-50. doi: 10.1182/blood-2004-08-3168. Epub 2005 Feb 1. Blood. 2005. PMID: 15687241 Free PMC article.

9

Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells.

Carter BZ, Mak DH, Schober WD, Cabreira-Hansen M, Beran M, McQueen T, Chen W, Andreeff M. Carter BZ, et al. Blood. 2006 Feb 15;107(4):1555-63. doi: 10.1182/blood-2004-12-4704. Epub 2005 Oct 27. Blood. 2006. PMID: 16254145 Free PMC article.

10

Apoptosis effector mechanisms: a requiem performed in different keys.

Hail N Jr, Carter BZ, Konopleva M, Andreeff M. Hail N Jr, et al. Among authors: carter bz. Apoptosis. 2006 Jun;11(6):889-904. doi: 10.1007/s10495-006-6712-8. Apoptosis. 2006. PMID: 16547589 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters